DVA

NEUTRALEarnings

DaVita Inc.

2026-07-28

Price

$239.46

+1.33%

This is the 2026-07-28 snapshot — the signals and analysis for DVA as of this single trading day.

View full DVA research hub →

Score4.2Watchlist

Signals4/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume0.9xvs 20d avg

Analysis

DaVita (DVA) is exhibiting High-Conviction Price Discovery, breaking out to all-time highs as capital rotates defensively amidst the CAUTION (EARNINGS) macro regime. While the broader market fixates on semiconductor and Big Tech anxiety, DVA's robust technical signals—including an ALPHA_MALE and PERFECT_STACK—are validated by a wave of recent analyst price target hikes up to $270. The stock's +9.0% relative strength versus the SPY highlights strong institutional absorption into defensive healthcare assets ahead of its August 4th earnings report.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSPERFECT STACKWEAK FINISH

Key Takeaways

Actionable Thesis: Ride the High-Conviction Price Discovery momentum into the August 4th earnings, supported by recent price target hikes (UBS to $270, Truist to $250) and strong relative strength.
Key Risk: An earnings miss or cautious forward guidance on August 4th could trigger a sharp mean-reversion, especially given the stock's 100%+ year-to-date run and technically overbought conditions.
What to Watch: Monitor the $222.48 structural support level; a breakdown below this 20-day closing low would invalidate the breakout thesis.

← Back to 2026-07-28 View Full DVA History →Yahoo Finance &nearr;